Changchun BCHT Biotechnology Co (SHSE:688276) COGS-to-Revenue : 0.10 (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Changchun BCHT Biotechnology Co COGS-to-Revenue?

Changchun BCHT Biotechnology Co's Cost of Goods Sold for the three months ended in Mar. 2024 was ¥28 Mil. Its Revenue for the three months ended in Mar. 2024 was ¥270 Mil.

Changchun BCHT Biotechnology Co's COGS to Revenue for the three months ended in Mar. 2024 was 0.10.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Changchun BCHT Biotechnology Co's Gross Margin % for the three months ended in Mar. 2024 was 89.72%.

Changchun BCHT Biotechnology Co COGS-to-Revenue Historical Data

The historical data trend for Changchun BCHT Biotechnology Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Changchun BCHT Biotechnology Co COGS-to-Revenue Chart

Changchun BCHT Biotechnology Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.10

0.12

0.13

0.10

Changchun BCHT Biotechnology Co Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.14	0.11	0.11	0.07	0.10

Changchun BCHT Biotechnology Co COGS-to-Revenue Calculation

Changchun BCHT Biotechnology Co's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	178.216	/	1824.689
	=	0.10

Changchun BCHT Biotechnology Co's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	27.791	/	270.288
	=	0.10

Changchun BCHT Biotechnology Co (SHSE:688276) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Changchun BCHT Biotechnology Co's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	27.791 / 270.288
	=	89.72 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Changchun BCHT Biotechnology Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Changchun BCHT Biotechnology Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Changchun BCHT Biotechnology Co (SHSE:688276) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Changchun BCHT Biotechnology Co (SHSE:688276) » Definitions » COGS-to-Revenue

Traded in Other Exchanges

N/A

Address

No. 1260, Huoju Road, High-tech Development Zone, Jilin Province, Changchun, CHN, 130012

Website

http://www.bchtpharm.com

Changchun BCHT Biotechnology Co is a biopharmaceutical enterprise specializing in the research and development, production and sales of human vaccines.

Executives

Shi Nian Min	Core technical personnel
Jiang Chun Lai	Directors, senior managers, core technical personn
Zhu Chang Lin	Core technical personnel
Wei Wei	Senior management, core technical personnel
Yu Bing	senior management
Liu Da Wei	Senior management, core technical personnel
Meng Zhao Feng	senior management
Zhang Zhe	senior management
Kong Wei	Directors, senior managers, core technical personn
Feng Da Qiang	Supervisors

Changchun BCHT Biotechnology Co (SHSE:688276) Headlines

No Headlines